-
Raquel Deering
Immune Oncology, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States
-
Wen Fury
Molecular Profiling, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States
-
Sunil K. Srivastava
Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
-
Se Jeong
Immune Oncology, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States
-
Sumit Sharma
Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
-
Kimberly Baynes
Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
-
Ashley Lowe
Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
-
Michael Ramos
Cole Eye Institute, Cleveland Clinic, Cleveland, Ohio, United States
-
Evangelia Malahias
Molecular Profiling, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States
-
Christina Adler
Molecular Profiling, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States
-
Min Ni
Molecular Profiling, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States
-
Yi Wei
Molecular Profiling, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States
-
Mickey Atwal
Molecular Profiling, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States
-
Carmelo Romano
Ophthalmology, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States
-
Gavin Thurston
Oncology & Angiogenesis, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States
-
jonathan weyne
Early Clinical Development, Regeneron Pharmaceuticals Inc, Tarrytown, New York, United States